<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05105399</url>
  </required_header>
  <id_info>
    <org_study_id>SAP Versione 2 del 05/06/2020</org_study_id>
    <nct_id>NCT05105399</nct_id>
  </id_info>
  <brief_title>Evaluation of Serratus Plane Block on the Respiratory Pattern in Patients With Multiple Rib Fractures</brief_title>
  <official_title>Evaluation of Serratus Plane Block on the Respiratory Pattern in Patients With Multiple Rib Fractures: a Perspective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Niguarda Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Niguarda Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients admitted following a trauma, the incidence of multiple rib fractures is reported&#xD;
      to be 9,7%, and this can be even higher in high energy trauma like motor vehicle accidents&#xD;
      (1). Pain deriving from rib fractures cause the patient to breath shallow in order to limit&#xD;
      discomfort and this bring about negative consequences: shallow breathing and inability to&#xD;
      clear secretions may cause pulmonary atelectasis eventually evolving to pneumonia. Given the&#xD;
      aforementioned concerns, it is easy to understand why, in a context like this, control of&#xD;
      chest pain become crucial. The best way to achieve adequate pain control have not yet been&#xD;
      established: the aim of this study is to investigate on this clinical dilemma. In this study,&#xD;
      72 people with at least two monolateral rib fractures are going to be randomized into three&#xD;
      groups: 1) standard treatment alone (intravenous analgesia: acetaminophen + morphine PCA); 2)&#xD;
      continuous serratus plane block + standard treatment; 3) single-shot serratus plane block +&#xD;
      standard treatment. The variables that are going to be recorded are the following: pain&#xD;
      through the NRS scale, FEV1 and FVC through spirometry and finally an arterious gas analysis.&#xD;
      Recording are going to be repeated at 72h after admission. The primary endpoint is to&#xD;
      evaluate if the continuous serratus plane block is able to improve the FEV1/FVC compared to&#xD;
      single shot or standard treatment alone. Secondary endpoints will be: the effect of&#xD;
      continuous block on 1) resting and incident pain; 2) opioid consumption; 3) blood gas&#xD;
      analysis parameters; 4) pulmonary complications at 1 month; 5) length of stay&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>FEV1 (% of the predicted value)</measure>
    <time_frame>72 hours</time_frame>
    <description>Any statistically significant difference between the two treatment groups and the control group will be measured. FEV1 is expected to be respectively 80±15% of the predicted value in the treatment groups and 64±15% of the predicted value in the control group</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Rib Fractures</condition>
  <condition>Spirometry</condition>
  <arm_group>
    <arm_group_label>Morphine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Single</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Serratus plane block (continuous or single-shot)</intervention_name>
    <description>Patients assigned to the interventional arms will receive either continuous serratus plane block or single-shot serratus plane block</description>
    <arm_group_label>Continuous</arm_group_label>
    <arm_group_label>Single</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Chest trauma with at least 2 monolateral rib fractures (monofocal or multifocal) with&#xD;
             no flail chest&#xD;
&#xD;
          2. Age&gt;18 years&#xD;
&#xD;
          3. Hospital admission&#xD;
&#xD;
          4. Ability to provide written informed consensus&#xD;
&#xD;
          5. Awake patient, spontaneous ventilation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antonio Giorgi, MD</last_name>
    <phone>+393208588471</phone>
    <email>antonio.giorgi@ospdaleniguarda.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>ASST GOM Niguarda</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Rib Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

